Information for Medical Professionals & Investors
Magstim® TMS therapy is an effective, non-invasive, outpatient treatment with few known adverse effects1. Magstim® TMS therapy is currently prescribed for the treatment of Major Depressive Disorder. Clinical trials are on-going into other areas.
The majority of depression episodes (>65%) result in non-remission after first-line treatment with any chosen anti-depressant medication.2 TMS is cost effective treatment which can be effective even in treatment resistant cases.
Transcranial Magnetic Stimulation (TMS) is a series of repetitive, brief and focused magnetic pulses, used to stimulate brain cells.
Magstim TMS therapy is a proven, safe and cost-effective treatment for Major Depressive Disorder, which is non-invasive, non-systemic and has few known adverse effects, resulting in better patient outcomes.
When a nerve cell ‘fires’, an electrical impulse travels along its length. It communicates with other nerve cells by releasing neuro-transmitters, which create an electrical impulse in other cells. In depressed patients, the electrical activity in certain areas of the brain have been shown to be reduced. TMS uses a focused electromagnetic coil, to rapidly pulse a magnetic field to the targeted area of the brain.
The magnetic pulses induce an electrical current in the brain, stimulating the nerve cells, increasing the brain activity to normal levels.
TMS is typically prescribed when antidepressants have failed, or the side effects have proven too disruptive to a patient’s lifestyle or system. This may be called treatment resistant depression, or TRD.²
Approximately 58% of patients with treatment resistant depression respond positively to TMS therapy, <37% of patients achieve complete remission.³
Other treatments for TRD include Electro-Convulsive Therapy (ECT), which works by applying a brief electrical pulse to the brain that medically induces a seizure. ECT is performed in a hospital under anaesthesia and can be associated with numerous side effects. TMS is a gentle, non-systemic, outpatient procedure with few known adverse effects associated. Patients can return to their daily activities after treatment.
We are proud to have the opportunity to make a real difference in peoples lives. We’ve created ‘Magstim TMS Stories’ to celebrate our patients. Head to the TMS stories page to read real testimonials from real TMS patients.
TMS is a safe and well-tolerated treatment with few known adverse effects. Clinical studies show that the most common side effects are mild to moderate scalp discomfort and mild headaches, both of which are short-term.4
TMS therapy is indicated for adults with Major Depressive Disorder, who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode.
Magstim® TMS therapy is a cost-effective solution for treatment-resistant depression. As an outpatient treatment, with a fast patient throughput, you can treat more patients every day and with a high remission rate, that’s changing more lives each year.
At Magstim® we pride ourselves on our customer service. We offer care packages to provide peace of mind, so that your clinic can provide treatment all year round and we can even help you promote your new TMS clinic; contact us for more information.
The Magstim TMS therapy product range features CE marked and FDA cleared packages* designed to treat patients in a doctors office, TMS clinic or clinical trial setting:
*Refer to individual product information for exact regulatory information.